Base Metals Investing Biomea Fusion Announces Completion of Enrollment of First 3 Arms in Phase 2 Expansion Cohorts of COVALENT-111 Study for BMF-219 in Type 2 Diabetes
Base Metals Investing Biomea Fusion Reports First Quarter 2024 Financial Results and Corporate Highlights
